Cell And Gene Therapy Market Scope And Analysis

Report Code : TIPRE00020854
Category : Life Sciences

Status : Published
No. of Pages : 232

Buy Now

Cell and Gene Therapy Market Trends and Scope by 2031

Buy Now

Cell and Gene Therapy Market Report Scope

Report Attribute	Details
Market size in 2023	US$ 4,485.00 Million
Market Size by 2031	US$ 28,050.39 Million
Global CAGR (2023 - 2031)	25.8%
Historical Data	2021-2022
Forecast period	2024-2031
Segments Covered	By Type Cell Therapy Gene Therapy By Services Process Development cGMP Manufacturing Regulatory Services Bioassay Services By Scale Pre Commercial/R and D Manufacturing Commercial Scale Manufacturing By Service Providers CDMOs CMOs
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Thermo Fisher Scientific Inc Merck KGaA Charles River Laboratories Cell and Gene Therapy Catapult Lonza WuXi AppTec Takara Bio Inc Bristol Myers Squibb FUJIFILM Holdings Corporation F Hoffmann La Roche Ltd

Cell and Gene Therapy Market News and Recent Developments

The cell and gene therapy market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the cell and gene therapy market are listed below:

South Korean CDMO Lotte Biologics and Merck KGaA have signed a partnership deal focused on expanding biopharmaceutical production and process development. (Source: Lotte Biologics, Company Website, June 2024)
Catalent launched a new case management service specifically designed to address the unique challenges associated with the safe and timely delivery of advanced therapies to patients by providing professional supply chain oversight from program start to finish. The supply chain logistics for advanced therapy medicinal products (ATMPs), such as cell and gene therapies, is complex because of their inherent sensitivity, high value, and certain patient-specific complexities of delivering each dose. (Source: Catalent, Company Website, January 2023)

Cell and Gene Therapy Market Report Coverage and Deliverables

The "Cell and Gene Therapy Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:

Cell and gene therapy market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
Cell and gene therapy market trends as well as market dynamics such as drivers, restraints, and key opportunities
Detailed PEST and SWOT analysis
Cell and gene therapy market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments.
Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the cell and gene therapy market.
Detailed company profiles